Costly Daraprim maker has $1-per-pill competition

Danielle Haynes SAN DIEGO, Oct. 23 (UPI) -- A company says it plans to sell a $1-per-pill alternative to Daraprim, a drug used to treat toxoplasmosis, which saw a 5,000 percent price increase.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.